Literature DB >> 10229506

Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.

M A Vasef1, R K Brynes, M Sturm, C Bromley, R A Robinson.   

Abstract

In this study, we assessed the frequency of cyclin D1 protein expression in normal and neoplastic parathyroid tissue (10 parathyroid carcinomas, 28 adenomas, 18 hyperplasias, and 32 normal parathyroid glands) with use of a monoclonal anticyclin D1 antibody and a heat-induced epitope retrieval method. Overexpression of cyclin D1 was identified in 10 (91%) of 11 biopsy specimens from 10 patients with parathyroid carcinomas and in 11 (39%) of 28 parathyroid adenomas. In addition, 11 (61%) of 18 cases of parathyroid hyperplasia also expressed cyclin D1 protein, an observation not reported previously. These results confirm the high frequency of cyclin D1 expression in parathyroid carcinomas and adenomas. In addition, the results of this study indicate that overexpression of cyclin D1 protein is not limited to neoplastic proliferations of parathyroid tissue but is also seen in non-neoplastic proliferations of parathyroid gland. Cyclin D1 protein expression was rarely (<6%) present in normal parathyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229506

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  39 in total

1.  Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.

Authors:  Sanjay M Mallya; H Irene Wu; Elizabeth A Saria; Kristin R Corrado; Andrew Arnold
Journal:  J Bone Miner Res       Date:  2010-07-16       Impact factor: 6.741

Review 2.  Immunohistochemistry in Diagnostic Parathyroid Pathology.

Authors:  Lori A Erickson; Ozgur Mete
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

3.  Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism.

Authors:  Alfredo Campennì; Rosaria M Ruggeri; Alessandro Sindoni; Salvatore Giovinazzo; Enrico Calbo; Antonio Ieni; Letterio Calbo; Giovanni Tuccari; Sergio Baldari; Salvatore Benvenga
Journal:  J Bone Miner Metab       Date:  2012-01-14       Impact factor: 2.626

4.  CDK4/6 Dependence of Cyclin D1-Driven Parathyroid Neoplasia in Transgenic Mice.

Authors:  Jessica Costa-Guda; Kristin Corrado; Justin Bellizzi; Robert Romano; Elizabeth Saria; Kirsten Saucier; Madison Rose; Samip Shah; Cynthia Alander; Sanjay Mallya; Andrew Arnold
Journal:  Endocrinology       Date:  2020-10-01       Impact factor: 4.736

Review 5.  Genetics of Hyperparathyroidism, Including Parathyroid Cancer.

Authors:  William F Simonds
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

6.  Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Authors:  D Scarpelli; L D'Aloiso; F Arturi; A Scillitani; I Presta; M Bisceglia; C Cristofaro; D Russo; S Filetti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 7.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

8.  Aberrant WNT/β-catenin signaling in parathyroid carcinoma.

Authors:  Jessica Svedlund; Maria Aurén; Magnus Sundström; Henning Dralle; Göran Akerström; Peyman Björklund; Gunnar Westin
Journal:  Mol Cancer       Date:  2010-11-15       Impact factor: 27.401

Review 9.  [Hyperplasia and tumors of the parathyroid glands].

Authors:  S-Y Sheu; F Otterbach; A Frilling; K W Schmid
Journal:  Pathologe       Date:  2003-06-19       Impact factor: 1.011

10.  HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.

Authors:  V M Howell; C J Haven; K Kahnoski; S K Khoo; D Petillo; J Chen; G J Fleuren; B G Robinson; L W Delbridge; J Philips; A E Nelson; U Krause; K Hammje; H Dralle; C Hoang-Vu; O Gimm; D J Marsh; H Morreau; B T Teh
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.